About
Spyre Therapeutics is a clinical-stage biotechnology company developing novel antibody therapies targeting immune-mediated gastrointestinal and rheumatic diseases, including inflammatory bowel disease.
Explore Spyre Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.